MK0657

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0657, covering 2015-01-29 to 2015-01-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MK0657 in Parkinson's Disease Patients (0657-006) [Phase 1]